In response to the coronavirus pandemic the Federal Council had declared that an extraordinary situation exists in Switzerland. Among other things this had an impact on arrangements relating to compulsory basic health and accident insurance.
Cost coverage for outpatient services and inpatient treatment
When the ‘extraordinary situation’ ended on 21 June 2020, the temporary recommendations and guidelines issued by the FOPH regarding coverage of the costs for certain outpatient services and inpatient treatment were revoked. Since then, a ‘particular situation’ under the terms of the Epidemics Act has existed in Switzerland. In view of the development of the epidemiological situation, the FOPH has taken up this issue again and updated the fact sheets listed below (in german, french and italian only).
Letter - Waiver of preceding confirmation of coverage ("vorgängige Kostengutsprache") due to the current Covid-19 situation (only in German (PDF, 99 kB, 23.11.2020) and French (PDF, 201 kB, 23.11.2020))
Since 25 June 2020, the federal government has assumed the costs of outpatient molecular biological analyses (e.g. PCR) and immunological (serological) analyses for antibodies for people meeting the FOPH's criteria for suspicion, sampling and reporting. Since 2 November 2020, the federal government has additionally assumed the costs of immunological analyses for Sars-CoV-2 antigens and Sars-CoV-2 rapid tests.
From 15 March 2021, testing will be extended again in step with the reopening of the economy. The federal government will now assume the costs for repetitive testing in companies and associations as well as Sars-CoV-2 rapid tests for specialist use for all persons. As soon as reliable tests for private use are available, each person will be able to obtain five tests for private use per month.
The document is available in German, French and Italian.
Last modification 29.03.2021